Major and minor salivary gland tumors.

@article{Guzzo2003MajorAM,
  title={Major and minor salivary gland tumors.},
  author={Marco Guzzo and Laura Deborah Locati and Franz Josef Prott and Gemma Gatta and Mark McGurk and Lisa Licitra},
  journal={Critical reviews in oncology/hematology},
  year={2003},
  volume={74 2},
  pages={
          134-48
        }
}
Malignant salivary gland tumors are rare. The most common tumor site is the parotid. Aetiologic factors are not clear. Nutrition may be a risk factor, as well as irradiation or a long-standing histologically benign tumor that occurs at youth. Painless swelling of a salivary gland should always be considered as suspicious, especially if no sign of inflammation is present. Signs and symptoms related to major salivary gland tumors differ from those concerning minor salivary gland tumors, as they… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 112 CITATIONS, ESTIMATED 60% COVERAGE

Extensive Regional Metastasis of High-Grade Mucoepidermoid Carcinoma of an Unknown Primary Tumor.

  • Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Kaplan–Meier analysis of salivary gland tumors: prognosis and long-term survival

  • Journal of Cancer Research and Clinical Oncology
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND & RESULTS

FILTER CITATIONS BY YEAR

2003
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 10 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 148 REFERENCES

C252 treatment relevant immunophenotyping

LD Locati, M Losa, F Perrone
  • 2005
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Cancer survival trends in England and Wales, 1971–1995: deprivation and NHS region. Studies in medical and population subjects

MP Coleman, P Babb, P Daniecki
  • no. 61. London: The Stationary Office
  • 1999
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

CM van Herpen, LD Locati, J Buter
  • Eur J Cancer
  • 2008
VIEW 8 EXCERPTS
HIGHLY INFLUENTIAL

Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

World Health Organization classification of tumours

L Barnes, JW Eveson, P Reichart, D. Sidransky
  • Lyon: IARC Press;
  • 2005
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Prognostic role of epidermal growth factor receptors 1 & 2, androgen receptor and kit in 111 salivary gland cancer

LD Locati, P Bossi, S Lo Vullo
  • In: 7th international conference on head & neck cancer
  • 2008
VIEW 3 EXCERPTS

Similar Papers

Loading similar papers…